Trial no.:
|
PACTR201712002844286 |
Date of Approval:
|
07/12/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
REMIND |
Official scientific title |
Effect of reminder cues and tailored feedback on adherence to antiretroviral drug treatment among people living with HIV in the Kilimanjaro region, Tanzania |
Brief summary describing the background
and objectives of the trial
|
People living with HIV (PLHIV) have to take lifelong treatment, which is often challenging. With this study, we aim to introduce an innovative, accessible and affordable means of improving adherence to antiretroviral treatment that exploits the large use of mobile phones in Tanzania and Sub-Saharan Africa and involves patients in their own care. The objective is to investigate the effect of short message service (SMS) and real time medication monitoring (RTMM), which both generate reminder cues and adherence performance reports for tailored feedback, on adherence to treatment among PLHIV in Kilimanjaro region, Tanzania. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
REMIND |
Disease(s) or condition(s) being studied |
Infections and Infestations |
Sub-Disease(s) or condition(s) being studied |
HIV/AIDS |
Purpose of the trial |
Supportive care |
Anticipated trial start date |
01/01/2017 |
Actual trial start date |
11/12/2017 |
Anticipated date of last follow up |
31/12/2019 |
Actual Last follow-up date |
28/02/2020 |
Anticipated target sample size (number of participants) |
264 |
Actual target sample size (number of participants) |
265 |
Recruitment status |
Completed |
Publication URL |
https://journals.lww.com/jaids/Fulltext/2021/08150/Effect_of_Digital_Adherence_Tools_on_Adherence_to.4.aspx |
|